ADAMTS5 and gastric cancer: More recently, ADAMTS5 was proposed as an independent prognostic factor for GC since its expression is downregulated by promoter methylation with a consequent increase of GC cell migration and invasive properties, and patients displaying higher ADAMTS5 levels are characterized by a better five-year overall survival rate [270].